<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/27712A22-4A77-441E-920C-DF224E26994E"><gtr:id>27712A22-4A77-441E-920C-DF224E26994E</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:otherNames>Fidelis</gtr:otherNames><gtr:surname>Cunningham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF022778%2F1"><gtr:id>AC7E2FFC-B101-4B2A-BEBD-999801CBF0A4</gtr:id><gtr:title>Activities of Salmonella flagellin: FliCing immunity on and off and from Th1 to Th2</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F022778/1</gtr:grantReference><gtr:abstractText>Infections caused by Salmonella have a massive impact on human and live-stock health. In terms of disease they are amongst the leading causes of gastroenteritis in the UK, but their impact in other countries is much more serious where Salmonella kills over a million people every year. Clearing a primary Salmonella infection requires Salmonella-specific CD4 T cells to become activated. These T cells then polarize to become one of two types, a Th1 or Th2 cell. Th1 cells are best at activating cells that actively kill and digest bacteria (macrophages). When the same infection is re-encountered other cell-types including B cells that can develop to produce antibody are also important for optimal immunity. One of the most, if not the most, commonly recognized T cell antigen from Salmonella is flagellin and it is also a major target of B cell responses. Flagellin is the major constituent of long whip-like structures called flagella that are anchored into the cell wall and involved in bacterial motility. Although not required for virulence their extension far beyond the wall of the bacterial cell, and strong recognition by the innate and adaptive immune system make them important to study. Because so much of this protein is exposed to the host it makes a good target for the host to target, but their location outside the bacterium also offers a means by which the bacterium can interact with and affect the host. We found the immune response to flagellin can alter to be Th1 or Th2 depending upon how the protein is encountered by the immune system. Despite provoking a strong immune response immunization with FliC does not protect against Salmonella infection. Indeed when flagellin was given alongside an effective live bacterial vaccine we showed it reduced protection by impairing the production of a key Th1 molecule IFNg. Under some circumstances we noticed that flagellin can induce a hypersensitivity reaction in the host. This was seen when flagellin protein was given when small numbers of bacteria were present after a previous Salmonella infection. In contrast, when the infection had resolved this hypersensitivity reaction was not seen. This is of significance since flagellin has been proposed as a possible adjuvant in humans. Thus flagellin offers many paradoxes such as being the major target of the immune response to Salmonella yet these responses may sometimes not protect or may even do harm, and flagellin is even dispensable for virulence. This project wants to expand our preliminary and published findings to understand more about the complex relationship between the host, flagellin and Salmonella. We wish to identify: 1. Why does flagellin induce a Th2 response and whether the direction of the T cell response induced against isolated flagellin can be altered from a Th2 response to a Th1 response that then offers protection against infection? 2. How the intrinsic properties of flagellin may harm the host? 3. Whether the dominance of the T cell response to this one antigen enhances clearance of bacteria from the host is a mechanism by which the bacterium evades immunity? We will do this by using a mouse model of infection and vaccination. Microscopy will be used to examine tissues and allow the identification of where cells reside such as flagellin-specific T and B cells. More detail on the phenotype of cells will be attained using flow cytometry and gene expression will be assessed by the polymerase chain reaction. The work will offer insights into i) whether this potent protein may be used in a vaccine by altering how it is given to the host; ii) how effective vaccines to Salmonella should be designed and iii) whether potential problems such as hypersensitivity responses can be avoided during the administration of vaccines.</gtr:abstractText><gtr:technicalSummary>Salmonella infections are major health and economic burdens in humans and live-stock. Resolution of primary infection requires CD4 Th1 cell interaction with macrophages whereas optimal immunity against reinfection also requires B cells. The TLR5 agonist flagellin is the immunodominant T cell antigen recognised during these infections, yet flagellin is dispensable for virulence. Our experiments suggest responses to flagellin can be double-edged. When given as a soluble protein a strong Th2 response is induced, yet the response to bacterial surface localised flagellin is Th1. Surprisingly, considering its immunodominance, vaccination with soluble flagellin is not protective even though high antibody titres are induced. Furthermore soluble flagellin can impair the protection afforded by a live vaccine in part by suppressing IFNg production from flagellin-specific CD4 T cells yet soluble FliC-primed Th2 transgenic T cells transferred into Rag1-/- mice can protect. Additionally flagellin can induce a hypersensitivity reaction in mice that have residual Salmonella infection. The aim of this project is to unravel the mechanisms by which these various positive and negative activities are mediated to improve vaccine design and reduce the disease burden caused by these infections in humans and live-stock. Specifically we wish to: 1. Identify if Th2 responses to soluble FliC can be redirected to Th1 and whether this improves protection to STm infection 2. To investigate the mechanism(s) by which flagellin's intrinsic properties can harm the host 3. To test whether the predominance of responses to flagellin in wild-type (WT) mice favours the host or the pathogen The purpose is to exploit the immunodominance of flagellin to improve the Th1 protection immune responses targeted against the protein offer. At the same time this needs to be achieved by understanding, and bypassing, the negative effects flagellin can have on the host.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-18</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-12-19</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>438458</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>University of Lund</gtr:description><gtr:id>1A635751-63A0-4DEB-9CF1-42C98BF02720</gtr:id><gtr:impact>The first manuscript from this work is in preparation</gtr:impact><gtr:outcomeId>54624634129237.67553198-1</gtr:outcomeId><gtr:partnerContribution>They provided unique models for our studies</gtr:partnerContribution><gtr:piContribution>The post-doctoral fellow Dr Adriana Flores-Langarica made two visits to Lund to work collaboratively on the project. The resources used (animal models, consumables etc) were covered by Lund. This is a significant cost and research benefit to us as it made available unique resources.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Immune Regulation</gtr:department><gtr:description>MRC Centre for Immune Regulation</gtr:description><gtr:id>35CE4621-1F14-4FDA-8A9E-3588AE680ECF</gtr:id><gtr:impact>From this collaboration nearly all of my publications and patent are due, in part, to this collaboration.</gtr:impact><gtr:outcomeId>hLsN67onaDd-1</gtr:outcomeId><gtr:partnerContribution>Access to material and equipment as well as MRC students</gtr:partnerContribution><gtr:piContribution>Contribution to a theme in the Centre: Induction and regulation of immunity in secondary lymphoid tissues. My work examining how immune responses develop to pathogens and their components offers broad cross-theme collaborations.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Babraham</gtr:description><gtr:id>E2E9548F-833F-4A42-BDCA-CBF1414D72F8</gtr:id><gtr:impact>The RNA-binding protein HuR is essential for the B cell antibody response.
Diaz-Mu&amp;ntilde;oz MD, Bell SE, Fairfax K, Monzon-Casanova E, Cunningham AF, Gonzalez-Porta M, Andrews SR, Bunik VI, Zarnack K, Curk T, Heggermont WA, Heymans S, Gibson GE, Kontoyiannis DL, Ule J, Turner M.
Nat Immunol. 2015 Apr;16(4):415-25. doi: 10.1038/ni.3115. Epub 2015 Feb 23.
PMID: 25706746 Free PMC Article</gtr:impact><gtr:outcomeId>56e00c1d2e9752.60227222-1</gtr:outcomeId><gtr:partnerContribution>They provide unique mouse models and reagents</gtr:partnerContribution><gtr:piContribution>We contribute to the collaboration through our immunohistology skills</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Minnesota</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Minnesota</gtr:description><gtr:id>4FF7BCC2-2575-4444-93F6-6B2406F5CCC2</gtr:id><gtr:impact>A paper in JI (21451112).</gtr:impact><gtr:outcomeId>NbDn3G2Da7N-1</gtr:outcomeId><gtr:partnerContribution>This was a joint project where we investigated the role of TLR5 in the maintenance of host homeostasis and T cell activation. Experiments were reproduced in both laboratories.</gtr:partnerContribution><gtr:piContribution>This was a joint project where we investigated the role of TLR5 in the maintenance of host homeostasis and T cell activation. Experiments were reproduced in both laboratories.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Secondary school student work experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>56CC8B05-47BF-4826-B0E3-3D47DA0D12DF</gtr:id><gtr:impact>1 student for work experience.

This has developed into a longer-term relationship. For instance, I will host another student next year and have arranged to talk at the school next year.</gtr:impact><gtr:outcomeId>pNEMgJCKCR4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7209B30A-E0B4-4831-B924-02FF99A2BCFE</gtr:id><gtr:impact>Talks at local schools about animal experimentation and immunology, vaccinology and infectious disease. During this it became clear it is important alos to offer career advice. This is something also pursued by members of my group

Increased awareness and involvement with other schools</gtr:impact><gtr:outcomeId>DGFMHUSSmfm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant from BBSRC</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>865F9B93-E8AF-4C52-8848-047ECEDAE585</gtr:id><gtr:outcomeId>54624b48c983b5.20318834</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>wellcome trust CRF</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>02378AAB-9131-4814-B8DC-4D7D36F61B75</gtr:id><gtr:outcomeId>54624c7ade4fd2.36883823</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>In this research project we examined how the immune response develops to a bacterial protein called flagellin. This particular flagellin comes from Salmonella and triggers an immune response through a molecule called TLR5. 

What we were able to show is that the immune response to flagellin shows some plasticity. This means it starts in one form but can then change. This can help improve the rate of clearance of infection if the protein is used as a vaccine. Using this protein we were able to show that it can be used as a &amp;quot;Trojan Horse&amp;quot; to drive immune responses in the gut when the protein is given as an injection. This is a significant property of flagellin because it is notoriously difficult to do this. This means we can use this protein to &amp;quot;carry&amp;quot; other antigens to the gut and enhance responses to them. This will make this a very powerful way to deliver new vaccines. research that has developed from this project is examining how we can best do this.</gtr:description><gtr:exploitationPathways>This is explained above. We have now used these findings to improve vaccine delivery to the gut and enhance the size of a response to a vaccine.</gtr:exploitationPathways><gtr:id>9ED85AD5-343A-41E8-A408-7681C5354C58</gtr:id><gtr:outcomeId>56e01a1303df86.12087814</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8CF9EF89-4992-4B6D-A359-0976E1A65717</gtr:id><gtr:title>Soluble flagellin coimmunization attenuates Th1 priming to Salmonella and clearance by modulating dendritic cell activation and cytokine production.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56e0099f77b017.74189568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B61188-F022-42F7-AB54-4FD0D39AB4AA</gtr:id><gtr:title>The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e50117f77a619640c23aad9a8a1599"><gtr:id>38e50117f77a619640c23aad9a8a1599</gtr:id><gtr:otherNames>Marshall JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d08908904cea99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9ED2101-E85E-48F3-B3BE-2D2FB7E0F0D2</gtr:id><gtr:title>Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25fd330244e67263d95f007b9964721b"><gtr:id>25fd330244e67263d95f007b9964721b</gtr:id><gtr:otherNames>Hart PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e009a051ff54.04609893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99A6F292-E77A-42DB-9BC0-E1AB51AA913E</gtr:id><gtr:title>Death receptor 3 is essential for generating optimal protective CD4? T-cell immunity against Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b09809cb8afe33cffca89350d4755b5"><gtr:id>8b09809cb8afe33cffca89350d4755b5</gtr:id><gtr:otherNames>Buchan SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_16204_24_22259035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDCA3957-6A4C-4409-AFFE-52F5797C0A1D</gtr:id><gtr:title>Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12aaff51ab345feb7fcf8bb4be590360"><gtr:id>12aaff51ab345feb7fcf8bb4be590360</gtr:id><gtr:otherNames>Hitchcock JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>56e009a011ad19.32901972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21AB31F0-FE61-4767-A785-B791D321F44B</gtr:id><gtr:title>Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/826cdc2ce0980c0b971111b73991889a"><gtr:id>826cdc2ce0980c0b971111b73991889a</gtr:id><gtr:otherNames>MacLennan CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>doi_53d06f06fab2d0bc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31A0EC39-27DA-4E63-A5AF-C121007DA1F0</gtr:id><gtr:title>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_53d0810810d908c9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6436BBE-9E66-43C4-9D56-38D8D9920107</gtr:id><gtr:title>T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Hb1x47pktY9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC386955-AACF-47CF-BBEC-73D128BA8E88</gtr:id><gtr:title>TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b25449dc93c012cdeef424141b7ac55"><gtr:id>2b25449dc93c012cdeef424141b7ac55</gtr:id><gtr:otherNames>Letran SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d08908902ca2af</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E40D77F3-BDB0-46E9-A0A9-F5C0129DE521</gtr:id><gtr:title>Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>546249669fbab8.52331914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C887A8E7-CBAF-4527-A418-A993984DC350</gtr:id><gtr:title>Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d08908907c6314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A3363F-9AA7-42C5-9F18-AC2284251AB0</gtr:id><gtr:title>The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7a6d7d0e33498ac7e643f15a8a12b9"><gtr:id>ac7a6d7d0e33498ac7e643f15a8a12b9</gtr:id><gtr:otherNames>Gil-Cruz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_53d039039efd6f9a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0C608B1-7023-4E9E-B808-5609FF5BB0DB</gtr:id><gtr:title>MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bc52e9d42241d299e7d67c73da363f"><gtr:id>e3bc52e9d42241d299e7d67c73da363f</gtr:id><gtr:otherNames>Reynolds LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5462430745a8c0.98042656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>526FF9CE-6925-4654-91D2-8130D9E53C91</gtr:id><gtr:title>Thymic function is maintained during Salmonella-induced atrophy and recovery.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16204_24_22993205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8D9F0C-DE4A-4DEB-B942-5965D5947141</gtr:id><gtr:title>Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>doi_53cfc3fc3ef7ca3a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FFC83A5-5284-408F-AEF4-68733147A6B6</gtr:id><gtr:title>CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d0890890237a79</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F022778/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>